We describe here the clinical aspects of hyperparathyroidism (HP) in Japane
se multiple endocrine neoplasia type 1 (MEN 1). The total number of MEN 1 p
atients was 37, and they originated from ten unrelated Japanese families. N
ine of the ten families were proven to have heterozygous germline mutations
of the MEN 1 gene. The incidence of HP, pituitary tumors, and pancreatic t
umors in 37 MEN 1 patients was 91.9%, 32.4%, and 45.9%, respectively. The a
ge-related penetrances of HP were 50%, 79%, 84%, by 20, 30, and 40 years of
age, respectively. Of these MEN 1 patients, we used 28 individuals, diagno
sed with KP at our hospitals, to study the clinical aspects of MEN 1-associ
ated HP. The mean age was 40 years, and the mean was much lower in the spor
adic (non-MEN 1) HP patients. The mean levels of calcium, phosphate, and in
tact PTH were 10.8 mg/dL, 2.3 mg/dL, and 178.0 pg/mL, respectively, and the
se were not different from those of sporadic HP patients. The levels of int
act PTH were positively correlated with age, suggesting that HP may be prog
ressive with time in MEN 1. The percentage of symptomatic HP was 36% in MEN
1, whereas it was 55% in sporadic HP patients. Although histopathological
findings revealed that all four parathyroid glands were involved in hyperpl
asia, imaging studies showed an enlargment of only the single parathyroid g
land in most patients. The combination of total parathyroidectomy and autop
lantation succeeding in improving HP in MEN 1. (C) 2000 Editions scientifiq
ues et medicales Elsevier SAS.